These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 18276616)

  • 1. New cardiovascular risk determinants do exist and are clinically useful.
    Smulders YM; Thijs A; Twisk JW
    Eur Heart J; 2008 Feb; 29(4):436-40. PubMed ID: 18276616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Doubts regarding the existence and clinical relevance of 'new' risk determinants of cardiovascular disease are unfounded].
    Smulders YM; Thijs A; Twisk JW
    Ned Tijdschr Geneeskd; 2008 Jul; 152(29):1610-3. PubMed ID: 18998267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New cardiovascular risk factors exist, but are they clinically useful?
    Wang TJ
    Eur Heart J; 2008 Feb; 29(4):441-4. PubMed ID: 18276617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are traditional risk factors valid for assessing cardiovascular risk in end-stage renal failure patients?
    Shah DS; Polkinghorne KR; Pellicano R; Kerr PG
    Nephrology (Carlton); 2008 Dec; 13(8):667-71. PubMed ID: 18761627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New statistical methods for the evaluation of cardiovascular risk markers: what the clinician should know.
    Røsjø H; Omland T
    Clin Sci (Lond); 2009 Jun; 117(1):13-5. PubMed ID: 19351327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated electronic decision support increases cardiovascular disease risk assessment four fold in routine primary care practice.
    Wells S; Furness S; Rafter N; Horn E; Whittaker R; Stewart A; Moodabe K; Roseman P; Selak V; Bramley D; Jackson R
    Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):173-8. PubMed ID: 18391644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New cardiovascular risk determinants do exist and are clinically useful.
    Levinson SS
    Eur Heart J; 2008 May; 29(10):1335; author reply 1335-6. PubMed ID: 18417459
    [No Abstract]   [Full Text] [Related]  

  • 8. Should the first priority in cardiovascular risk management be those with prior cardiovascular disease?
    Kerr AJ; Broad J; Wells S; Riddell T; Jackson R
    Heart; 2009 Feb; 95(2):125-9. PubMed ID: 18381374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement factor H Y402H decreases cardiovascular disease risk in patients with familial hypercholesterolaemia.
    Koeijvoets KC; Mooijaart SP; Dallinga-Thie GM; Defesche JC; Steyerberg EW; Westendorp RG; Kastelein JJ; van Hagen PM; Sijbrands EJ
    Eur Heart J; 2009 Mar; 30(5):618-23. PubMed ID: 19098018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of risk prediction models in cardiovascular disease research.
    Cui J
    Ann Epidemiol; 2009 Oct; 19(10):711-7. PubMed ID: 19628409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of C-reactive protein for cardiovascular risk stratification across three age groups in subjects without existing cardiovascular diseases.
    Hamer M; Chida Y; Stamatakis E
    Am J Cardiol; 2009 Aug; 104(4):538-42. PubMed ID: 19660608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentially modifiable risk factors associated with myocardial infarction in China: the INTERHEART China study.
    Teo KK; Liu L; Chow CK; Wang X; Islam S; Jiang L; Sanderson JE; Rangarajan S; Yusuf S;
    Heart; 2009 Nov; 95(22):1857-64. PubMed ID: 19482846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation.
    van Halm VP; Peters MJ; Voskuyl AE; Boers M; Lems WF; Visser M; Stehouwer CD; Spijkerman AM; Dekker JM; Nijpels G; Heine RJ; Bouter LM; Smulders YM; Dijkmans BA; Nurmohamed MT
    Ann Rheum Dis; 2009 Sep; 68(9):1395-400. PubMed ID: 18697775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasting and postchallenge hyperglycemia and risk of cardiovascular disease in Chinese: the Chin-Shan Community Cardiovascular Cohort study.
    Chien KL; Hsu HC; Su TC; Chen MF; Lee YT; Hu FB
    Am Heart J; 2008 Nov; 156(5):996-1002. PubMed ID: 19061718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk can be represented by scaled rectangle diagrams.
    Marshall RJ
    J Clin Epidemiol; 2009 Sep; 62(9):998-1000. PubMed ID: 19635404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic obstructive pulmonary disease and cardiovascular system].
    Gürgün A; Gürgün C
    Tuberk Toraks; 2008; 56(4):464-71. PubMed ID: 19123087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: a prospective cohort study.
    Knuiman MW; Hung J; Divitini ML; Davis TM; Beilby JP
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):235-41. PubMed ID: 19238082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
    Metcalf PA; Wells S; Scragg RK; Jackson R
    N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Doubts regarding the existence and clinical relevance of 'new' risk determinants of cardiovascular disease are unfounded].
    Visseren FL; van der Graaf Y
    Ned Tijdschr Geneeskd; 2008 Nov; 152(45):2480; author reply 2480-1. PubMed ID: 19051802
    [No Abstract]   [Full Text] [Related]  

  • 20. Ethnic differences in cardiovascular disease risk factors and diabetes status for Pacific ethnic groups and Europeans in the Diabetes Heart and Health Survey (DHAH) 2002-2003, Auckland New Zealand.
    Sundborn G; Metcalf PA; Gentles D; Scragg RK; Schaaf D; Dyall L; Black P; Jackson R
    N Z Med J; 2008 Sep; 121(1281):28-39. PubMed ID: 18797481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.